Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile
Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile
[EN] (S)-ALPHA-FLUOROMETHYLTYROSINE AS DECARBOXYLASE INHIBITORS FOR USE IN THE TREATMENT OF HYPOTENSION<br/>[FR] (S)-ALPHA-FLUOROMÉTHYLTYROSINE EN TANT QU'INHIBITEURS DE DÉCARBOXYLASE POUR UNE UTILISATION DANS LE TRAITEMENT DE L'HYPOTENSION
申请人:SENDA BIOSCIENCES INC
公开号:WO2021247963A1
公开(公告)日:2021-12-09
Provided are methods of using and drug delivery systems comprising inhibitors of pathogenic, bacterial metabolite production and conjugates of the inhibitors.
提供了使用抑制病原体、细菌代谢产物生产的方法和包含这些抑制剂的药物输送系统。
Belokon, Yuri N.; Bakhmutov, Vladimir I.; Chernoglazova, Nina I., Journal of the Chemical Society. Perkin transactions I, 1988, p. 305 - 312
作者:Belokon, Yuri N.、Bakhmutov, Vladimir I.、Chernoglazova, Nina I.、Kochetkov, Konstantin A.、Vitt, Sergei V.、et al.
DOI:——
日期:——
SUBSTITUTED TETRA- AND PENTAPEPTIDE INHIBITORS OF PROTEIN:FARNESYL TRANSFERASE
申请人:PARKE DAVIS & COMPANY
公开号:EP0725790A1
公开(公告)日:1996-08-14
[EN] SUBSTITUTED TETRA- AND PENTAPEPTIDE INHIBITORS OF PROTEIN:FARNESYL TRANSFERASE<br/>[FR] TETRA ET PENTAPEPTIDES SUBSTITUES INHIBITEURS DE LA FARNESYL-TRANSFERASE PROTEINIQUE
申请人:PARKE, DAVIS & COMPANY
公开号:WO1995011917A1
公开(公告)日:1995-05-04
(EN) Inhibitors of protein: farnesyl transferase enzyme are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in controlling tissue proliferative diseases, including cancer and restenosis.(FR) L'invention porte sur des inhibiteurs de la farnésyl-transférase protéinique et sur le procédé de préparation desdits inhibiteurs et de leurs compositions pharmaceutiques, qui s'avèrent utiles dans le contrôle des maladies à prolifération tissulaire y compris le cancer et la sténose récidivante.
Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile